Evidence map›Paper›PMID 38445252›Full record

ReviewInfectious Disease Modelling2024

Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report.

Marta C Nunes, Edward Thommes, Holger Fröhlich, Antoine Flahault, Julien Arino, Marc Baguelin, Matthew Biggerstaff, Gaston Bizel-Bizellot, Rebecca Borchering, Giacomo Cacciapaglia and 26 more

Abstract readReview
In one paragraph

Review in Infectious Disease Modelling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Marta C NunesCenter of Excellence in Respiratory Pathogens (CERP), Hospices Civils de Lyon (HCL) and Centre International de Recherche en Infectiologie (CIRI), Équipe Santé Publique, Épidémiologie et Écologie Évolutive des Maladies Infectieuses (PHE3ID), Inserm U1111, CNRS UMR5308, ENS de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Edward ThommesNew Products and Innovation (NPI), Sanofi Vaccines (Global), Toronto, Ontario, Canada.
Holger FröhlichFraunhofer Institute for Algorithms and Scientific Computing (SCAI), Department of Bioinformatics, Schloss Birlinghoven, Sankt Augustin, Germany.
Antoine FlahaultInstitute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland and Swiss School of Public Health, Zürich, Switzerland.
Julien ArinoDepartment of Mathematics, University of Manitoba, Winnipeg, Manitoba, Canada.
Marc BaguelinMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Matthew BiggerstaffNational Center for Immunization and Respiratory Diseases (NCIRD), US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Gaston Bizel-BizellotDepartement of Computational Biology, Departement of Global Health, Institut Pasteur, Paris, France.
Rebecca BorcheringNational Center for Immunization and Respiratory Diseases (NCIRD), US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Giacomo CacciapagliaInstitut de Physique des Deux Infinis de Lyon (IP2I), UMR5822, IN2P3/CNRS, Université Claude Bernard Lyon 1, Villeurbanne, France.
Simon CauchemezMathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Université Paris Cité, UMR2000 CNRS, Paris, France.
Alex Barbier-ChebbahDecision and Bayesian Computation, Institut Pasteur, Université Paris Cité, CNRS UMR 3571, France.
Carsten ClaussenFraunhofer-Institute for Translational Medicine and Pharmacology, Hamburg, Germany.
Christine ChoiratInstitute of Global Health, Faculty of Medicine, University of Geneva, Switzerland.
Monica CojocaruMathematics & Statistics Department, College of Engineering and Physical Sciences, University of Guelph, Guelph, Ontario, Canada.
Catherine Commaille-ChapusImpact Healthcare, Paris, France.
Chitin HonRespiratory Disease AI Laboratory on Epidemic Intelligence and Medical Big Data Instrument Applications, Department of Engineering Science, Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macau, China.
Jude KongAfrica-Canada Artificial Intelligence and Data Innovation Consortium (ACADIC), Global South Artificial Intelligence for Pandemic and Epidemic Preparedness and Response Network (AI4PEP), Laboratory for Industrial and Applied Mathematics (LIAM), Department of Mathematics and Statistics, York University, Toronto, Ontario, Canada.
Nicolas LambertQuinten Health, Paris, France.
Katharina B LauerAirfinity Ltd, London, UK.
Thorsten LehrClinical Pharmacy, Saarland University, Saarbrücken, Germany.
Cédric MaheSanofi Vaccine, Lyon, France.
Vincent MarechalSorbonne Université, INSERM, Centre de Recherche Saint-Antoine, Paris, France.
Adel MebarkiKap Code, Paris, France.
Seyed MoghadasAgent-Based Modelling Laboratory, York University, Toronto, Ontario, Canada.
Rene NiehusEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Lulla OpatowskiUMR 1018, Team "Anti-infective Evasion and Pharmacoepidemiology", Université Paris-Saclay, UVSQ, INSERM, France.
Francesco ParinoSorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health, Paris, France.
Gery PruvostLifen, Paris, France.
Andreas SchuppertInstitute for Computational Biomedicine, RWTH Aachen University, Aachen, Germany.
Rodolphe ThiébautBordeaux University, Department of Public Health, Inserm UMR 1219 Bordeaux Population Health Research Center, Inria SISTM, Bordeaux, France.
Andrea Thomas-BachliBlueDot, Toronto, Ontario, Canada.
Cecile ViboudFogarty International Center, National Institutes of Health, Bethesda, MD, USA.
Jianhong WuYork Emergency Mitigation, Engagement, Response, and Governance Institute, Laboratory for Industrial and Applied Mathematics, York University, Toronto, Ontario, Canada.
Pascal CrépeyEHESP, Université de Rennes, CNRS, IEP Rennes, Arènes - UMR 6051, RSMS - Inserm U 1309, Rennes, France.
Laurent CoudevilleSanofi Vaccine, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In July 2023, the Center of Excellence in Respiratory Pathogens organized a two-day workshop on infectious diseases modelling and the lessons learnt from the Covid-19 pandemic. This report summarizes the rich discussions that occurred during the workshop. The workshop participants discussed multisource data integration and highlighted the benefits of combining traditional surveillance with more novel data sources like mobility data, social media, and wastewater monitoring. Significant advancements were noted in the development of predictive models, with examples from various countries showcasing the use of machine learning and artificial intelligence in detecting and monitoring disease trends. The role of open collaboration between various stakeholders in modelling was stressed, advocating for the continuation of such partnerships beyond the pandemic. A major gap identified was the absence of a common international framework for data sharing, which is crucial for global pandemic preparedness. Overall, the workshop underscored the need for robust, adaptable modelling frameworks and the integration of different data sources and collaboration across sectors, as key elements in enhancing future pandemic response and preparedness.

Indexed as

Covid-19Infectious diseasesModellingPandemic preparednessWorkshop

Identifiers

PMID38445252
PMCPMC10912817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.